| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-13 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.24 | 4e-08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 6e-07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |